reduce basal insulin when starting glp-1 receptor agonist Glucagon‐like peptide‐1 (GLP‐1RA) mechanisms of action GLP-1-based therapies for type 2
Description
Meier JJ
GLP-1s often work better for both goals
A methodological framework for meta-analysis and clinical interpretation of subgroup data: the case of major adverse cardiovascular events with GLP-1 receptor agonists and SGLT2 inhibitors in type 2 diabetes
Cell 185 , 11301142.e1111 (2022)
How to diagnose sarcopenic obesity in candidates for bariatric surgery
They may also counsel on various nonpharmacologic treatments that may benefit patients with PD, including exercise to improve balance, flexibility, and motor coordination
